4basebio PLC

530.00pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:4BBHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 6Y CAGR 6.27%
Div yield —
ROE (177.98%)
Biotechnology
Beta (5Y) 0.81
PE TTM —
TSR TTM (32.91%)
Mkt cap £82.35M
ROIC (36.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
520p
(1.92%)
(87.11%)
Hold 12|5|4|11|12
4Q25
1Q26
2Q26
3Q26
Earnings per share£
7.92
8.07
8.67
9.05
24.55%
21.17%
19.15%
16.58%
Revenue£M
5.563
5.622
5.597
5.710
10.26%
5.46%
5.06%
7.33%
Peers (US$110.0M)
Cap (US$)
PE
137.1M
13.58x
Capital
TTM
5Y
10Y
Leveragex
1.617
0.709
0.537
EBIT/Intx
0.319
0.086
0.086
Own earn%
19.53
(42.78)
(47.15)
Sh yield%
32.64
31.18
30.54
Owners
Insiders/Inst%
5.65
44.29
Short interest%
4.74
SBC / revenue%
1.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
16–20
$1 testx
—
Incr. ROIC%
1